These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31864918)

  • 1. Evaluating the impact of Georgia's hepatitis C elimination plan: lessons learned for the global initiative.
    Hutin Y; Luhmann N; Easterbrook P
    Lancet Glob Health; 2020 Feb; 8(2):e163-e164. PubMed ID: 31864918
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination.
    Hagan LM; Kasradze A; Salyer SJ; Gamkrelidze A; Alkhazashvili M; Chanturia G; Chitadze N; Sukhiashvili R; Shakhnazarova M; Russell S; Blanton C; Kuchukhidze G; Baliashvili D; Hariri S; Ko S; Imnadze P; Drobeniuc J; Morgan J; Averhoff F
    BMC Public Health; 2019 May; 19(Suppl 3):480. PubMed ID: 32326913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and linkage to care for hepatitis C among inpatients in Georgia's national hospital screening program.
    Shadaker S; Nasrullah M; Gamkrelidze A; Ray J; Gvinjilia L; Kuchuloria T; Butsashvili M; Getia V; Metreveli D; Tsereteli M; Tsertsvadze T; Link-Gelles R; Millman AJ; Turdziladze A; Averhoff F
    Prev Med; 2020 Sep; 138():106153. PubMed ID: 32473265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
    Tsertsvadze T; Gamkrelidze A; Nasrullah M; Sharvadze L; Morgan J; Shadaker S; Gvinjilia L; Butsashvili M; Metreveli D; Kerashvili V; Ezugbaia M; Chkhartishvili N; Abutidze A; Kvaratskhelia V; Averhoff F
    BMC Infect Dis; 2020 Jan; 20(1):30. PubMed ID: 31924172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Georgia's approach to elements of planning for administrative action.
    RICE GV
    Public Health Rep (1896); 1954 Jan; 69(1):48-50. PubMed ID: 13121194
    [No Abstract]   [Full Text] [Related]  

  • 6. An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015.
    Harris AM; Chokoshvili O; Biddle J; Turashvili K; Japaridze M; Burjanadze I; Tsertsvadze T; Sharvadze L; Karchava M; Talakvadze A; Chakhnashvili K; Demurishvili T; Sabelashvili P; Foster M; Hagan L; Butsashvili M; Morgan J; Averhoff F
    BMC Public Health; 2019 May; 19(Suppl 3):466. PubMed ID: 32326938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Georgia's voluntary multiple health tests; a sixth year progress report.
    PETRIE LM; FETZ RH
    Occup Health (Wash D C); 1952 Nov; 12(11):172-3. PubMed ID: 12983005
    [No Abstract]   [Full Text] [Related]  

  • 8. Excellence in viral hepatitis elimination - Lessons from Georgia.
    Averhoff F; Lazarus JV; Sergeenko D; Colombo M; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Hellard M; Gnes S; Gabunia T; Nasrullah M
    J Hepatol; 2019 Oct; 71(4):645-647. PubMed ID: 31356831
    [No Abstract]   [Full Text] [Related]  

  • 9. Georgia's public-health problems.
    Music S
    Lancet; 1996 Dec 21-28; 348(9043):1738-9. PubMed ID: 8973456
    [No Abstract]   [Full Text] [Related]  

  • 10. Reforming Georgia's mental health system.
    Elliott RL; Cohen MD; Evans DL
    Community Ment Health J; 1995 Oct; 31(5):413-23. PubMed ID: 8556849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis C virus antibody positivity on mortality and causes of death in people living with HIV in Georgia.
    Chkhartishvili N; Bolokadze N; Rukhadze N; Dvali N; Abutidze A; Sharvadze L; Tsertsvadze T
    Int J STD AIDS; 2019 Oct; 30(12):1185-1193. PubMed ID: 31558133
    [No Abstract]   [Full Text] [Related]  

  • 12. Lessons Learned from Georgia's 2010
    Wells T
    J Leg Med; 2020; 40(1):45-52. PubMed ID: 32400310
    [No Abstract]   [Full Text] [Related]  

  • 13. CONFIDENCE IN THE GEORGIA NATIONAL HCV ELIMINATION PROGRAM AMONG WOMEN OF REPRODUCTIVE AGE.
    Gamezardashvili A; Butsashvili M; Kajaia M; Gulbiani L; Abashidze G; Kapanadze M; McNutt LA; Kamkamidze G
    Georgian Med News; 2019 Oct; (295):105-109. PubMed ID: 31804209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Georgia's healthcare system and integration of complementary medicine.
    Nadareishvili I; Pkhakadze G; Tskitishvili A; Bakuradze N; Lunze K
    Complement Ther Med; 2019 Aug; 45():205-210. PubMed ID: 31331562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex evaluation of climate-change--an example from Georgia's landscapes.
    Nikolaishvili D; Trapaidze V; Kalandadze B; Mamukashvili T; Sharashenidze M
    J Environ Biol; 2015 Jan; 36 Spec No():43-9. PubMed ID: 26591881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroscience in the Republic of Georgia.
    Burchuladze R
    Trends Neurosci; 1991 Apr; 14(4):131-2. PubMed ID: 1710847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV elimination - lessons learned from a small Eurasian country, Georgia.
    Nasrullah M; Sergeenko D; Gamkrelidze A; Averhoff F
    Nat Rev Gastroenterol Hepatol; 2017 Jul; 14(8):447-448. PubMed ID: 28743936
    [No Abstract]   [Full Text] [Related]  

  • 18. Georgia's plan for increased hospital facilities and health centers.
    LUNSFORD GG
    J Med Assoc Ga; 1948 Feb; 37(2):39-44. PubMed ID: 18916267
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergency medical response strategy proved critical to sustaining Georgia's health infrastructure.
    Mason C
    CMAJ; 2008 Oct; 179(8):762-3. PubMed ID: 18838448
    [No Abstract]   [Full Text] [Related]  

  • 20. Shared vision, collective impact, and persistent challenges: the first decade of Georgia's oncology research network.
    Paris NM; Burke JJ; Schnell FM
    J Oncol Pract; 2013 Nov; 9(6):283-6. PubMed ID: 24130253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.